Mr Andy Lafontant, PA-C in East Point, GA - Medicare Physician Assistant

Mr Andy Lafontant, PA-C is a medicare enrolled "Physician Assistant" physician in East Point, Georgia. His current practice location is 1170 Cleveland Ave, East Point, Georgia. You can reach out to his office (for appointments etc.) via phone at (404) 466-1654.

Mr Andy Lafontant is licensed to practice in Florida (license number PA9102384) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1902901887.

Contact Information

	Mr Andy Lafontant, PA-C
	1170 Cleveland Ave, East Point, GA 30344-3615
	(404) 466-1654
	Not Available

Physician's Profile

Full Name	Mr Andy Lafontant
Gender	Male
Speciality	Physician Assistant
Location	1170 Cleveland Ave, East Point, Georgia
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1902901887
Provider Enumeration Date: 09/14/2006
Last Update Date: 04/27/2011

Medicare PECOS Information:

PECOS PAC ID: 4789641663
Enrollment ID: I20100421000560

Medical Identifiers

Medical identifiers for Mr Andy Lafontant such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902901887	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	004404 (Georgia)	Secondary
363A00000X	Physician Assistant	PA9102384 (Florida)	Primary
363A00000X	Physician Assistant	004404 (Georgia)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Andy Lafontant is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Andy Lafontant, PA-C 195 14th St Ne, Suite 1405, Atlanta, GA 30309-2671 Ph: (914) 584-0541	Mr Andy Lafontant, PA-C 1170 Cleveland Ave, East Point, GA 30344-3615 Ph: (404) 466-1654

News Archive

CIGNA announces initial results of its multi-year strategy to improve customer's experience

CIGNA (NYSE:CI) today announced the initial results of its multi-year strategy that places an entirely new focus on improving customers' experience. The effort has led to an improvement in customer understanding of their benefits in excess of 100 percent, a 50 percent reduction in the number of printed materials customers receive, and the use of simpler language that doesn't rely on insurance jargon. It also led CIGNA to become the first in its industry to offer 24 hour-a-day, seven day-a-week customer service.

Packaging Coordinators, Inc., to exhibit service offerings at CPhI 2013

Packaging Coordinators, Inc. (PCI), a global supplier of pharmaceutical commercial packaging solutions and clinical trials services is pleased to announce that it will be exhibiting its full range of services on booth 41M15 at CPhI Worldwide. Exhibiting for the first time as Packaging Coordinators, inc. since May 2013 when AndersonBrecon merged with and operated as Frazier Healthcare's portfolio company, PCI, the company is now one of the largest suppliers of packaging supply services to the pharmaceutical industry and will be demonstrating its capabilities in clinical trials, in laboratory services and commercial services for pharmaceutical and biopharmaceutical customers.

Old skin fungus drug has been found to be a possible cancer treatment

A drug that has been used for 40 years for the treatment of skin fungus has been found to be a possible cancer treatment, according to an international team of scientists. Leslie Wilson, professor of biochemistry and pharmacology at the University of California, Santa Barbara, said that the antifungal drug, griseofulvin, has been shown to inhibit the growth of cancer cells in his laboratory.

Risk for cardiovascular disease begins early in life

A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease (CVD). In a four-country survey sample of 4,000 adults, 49 per cent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke.

Mr Andy Lafontant, PA-C - Medicare Physician Assistant in East Point, GA